Current:Home > StocksLeah Remini earns college degree at age 53: "It's never too late to continue your education" -WealthSphere Pro
Leah Remini earns college degree at age 53: "It's never too late to continue your education"
View
Date:2025-04-13 03:06:48
Former "King of Queens" actor Leah Remini has a message for those interested in pursuing a college degree later in life: "It's never too late to continue your education."
Remini, 53, posted on social media on Thursday that she received an associate's degree from New York University —a feat she's been working on for the past three years. Remini said she embarked on this "terrifying journey" after only having an eighth grade education and spending 35 years in a "totalitarian cult," referring to the Church of Scientology.
"I desperately wanted a higher education for many years but didn't move forward because I feared I was not smart enough," she said. "Even though I had managed to leave Scientology, three decades of brainwashing still gripped my mind."
But thanks to the support of family and friends, she went ahead in her pursuit. The "So You Think You Can Dance?" judge told her fans that she's now aiming to get a bachelor's degree.
"Whether a cult used to control your life, you have a full-time job as a stay-at-home parent, or full-time job(s) outside of the home, it's never too late to continue your education and pursue what you have always wanted to achieve for yourself!" she wrote.
Remini has been an outspoken critic of the Church of Scientology for years. She left the church in 2013 after being a member since childhood, and last year she sued the organization and its leader, David Miscavige, alleging she's been the victim of harassment, intimidation, surveillance and defamation.
Earlier this month, a judge threw out parts of the lawsuit, Variety reported, saying some of the church's attacks on her are protected under the First Amendment. However, the judge also found the church can't claim protection under free speech for allegedly harassing and surveilling Remini or employees associated with her anti-Scientology podcast.
- In:
- Leah Remini
Christopher Brito is a social media manager and trending content writer for CBS News.
veryGood! (6)
Related
- 'Malcolm in the Middle’ to return with new episodes featuring Frankie Muniz
- This Week in Clean Economy: Can Electric Cars Win Over Consumers in 2012?
- Florida bans direct-to-consumer auto sales but leaves carve-out for Tesla
- Jeremy Renner Jogs for the First Time Since Snowplow Accident in Marvelous Health Update
- Rylee Arnold Shares a Long
- Dakota Pipeline Builder Under Fire for Ohio Spill: 8 Violations in 7 Weeks
- Is Climate Change Fueling Tornadoes?
- Surviving long COVID three years into the pandemic
- Apple iOS 18.2: What to know about top features, including Genmoji, AI updates
- Exxon Loses Appeal to Keep Auditor Records Secret in Climate Fraud Investigation
Ranking
- Nearly 400 USAID contract employees laid off in wake of Trump's 'stop work' order
- Neurotech could connect our brains to computers. What could go wrong, right?
- Dakota Pipeline Builder Rebuffed by Feds in Bid to Restart Work on Troubled Ohio Gas Project
- Tweeting directly from your brain (and what's next)
- Rylee Arnold Shares a Long
- Opioids are devastating Cherokee families. The tribe has a $100 million plan to heal
- Electric Vehicle Advocates See Threat to Progress from Keystone XL Pipeline
- A Plant in Florida Emits Vast Quantities of a Greenhouse Gas Nearly 300 Times More Potent Than Carbon Dioxide
Recommendation
Justice Department, Louisville reach deal after probe prompted by Breonna Taylor killing
‘Essential’ but Unprotected, Farmworkers Live in Fear of Covid-19 but Keep Working
Kobe Bryant’s Daughter Natalia Bryant Gets in Formation While Interning for Beyoncé
EPA’s Methane Estimates for Oil and Gas Sector Under Investigation
2025 'Doomsday Clock': This is how close we are to self
Exxon Shareholders Approve Climate Resolution: 62% Vote for Disclosure
The potentially deadly Candida auris fungus is spreading quickly in the U.S.
Sickle cell patient's success with gene editing raises hopes and questions